Groups by Stem Cell Treatment

Stem Cell Transplant/Rescue

Terms

Autologous transplants where patients receive their own stem cells.

Allogeneic transplants where patients receive stem cells from their brother, sister, or parent, or unknown matched donor.

Myeloablative Allogeneic Transplant -Patient receives high dose chemotherapy to prepare a disease free environment for 'new' host donated stem cells. Risk of patient developing a host vs graft reaction.

Nonmyeloablative Transplant -Low dose or standard chemotherapy used to prepare patient for stem cells. Takes a longer period of time to graft and also longer to notice a host vs graft reaction.

Mini Transplant is a reduced stem cell treatment with lower doses.

Tandem Transplant is two transplants in a row'

Graft vs Host -a reaction that can develop when a patients body rejects the donated 'new' stem cells.

High Dose Chemotherapy Used for Stem Cell

Comgination: Busulfan, Melphalan and Thiotepa

Combination: Cyclophosphamid, Carboplatin & Thiotepa

Combination: Thiotepa and Carboplatin

Combination: VP-16, Thiotepa, and Cytoxan with Mesna

Combination: Etoposide, Carboplatiunum, and single dose of Melphalan

Combination: Cyclophosphamide, Busulphan along with Phenytoin, Ciprofloxacin, Fluconazole and Clexane. Melphalan.

See: Treatment Options Stem Cell

Patients